Despite clinical guidelines recommending the use of DOT for chlamydia treatment in adolescents, this is the first study to describe the association between DOT and an increase in the number of adolescents and young adults who return for STI retesting within six months. Further research is needed to confirm this finding in diverse populations and explore non-traditional settings for the provision of DOT.